For patients

Information on objectives, inclusion criteria, and procedures of the registry study.

For doctors

Information on the registry study, study management, and study centers.


TREATswitzerland is the patient registry for atopic dermatitis (neurodermatitis) in Switzerland. To date, there is a lack of accurate data on the medical care of patients with atopic dermatitis, the course of the disease and response to treatment, and the impact on quality of life. In an observational study of patients with moderate and severe atopic dermatitis, data will be collected and scientifically evaluated (observational cohort study).

This objective of the register study should be reflected in the illustrations. In addition, we want to give the patients a face – the burden that neurodermatitis brings with it, as well as show the positive effect of an effective therapy.


Second study center in French-speaking Switzerland

First study center in the french part of Switzerland

Opening of further study centers

Opening of new study centers